Cited by 110Dermatology and Skin DiseasesAsthma and respiratory diseasesIL-33, ST2, and ILC Pathways

Intradermal Administration of Thymic Stromal Lymphopoietin Induces a T Cell- and Eosinophil-Dependent Systemic Th2 Inflammatory Response

Jessup, Heidi K, Brewer, Avery W, Omori, Miyuki, Rickel, Erika A, Budelsky, Alison L, Yoon, Bo-Rin Park, Ziegler, Steven F, Comeau, Michael R·2008·The Journal of Immunology

Abstract

The epithelial-derived cytokine thymic stromal lymphopoietin (TSLP) is sufficient to induce asthma or atopic dermatitis-like phenotypes when selectively overexpressed in transgenic mice, or when driven by topical application of vitamin D3 or low-calcemic analogues. Although T and B cells have been reported to be dispensable for the TSLP-induced inflammation in these models, little is known about the downstream pathways or additional cell types involved in the inflammatory response driven by TSLP. To characterize the downstream effects of TSLP in vivo, we examined the effects of exogenous administration of TSLP protein to wild-type and genetically deficient mice. TSLP induced a systemic Th2 inflammatory response characterized by increased circulating IgE and IgG1 as well as increased draining lymph node size and cellularity, Th2 cytokine production in draining lymph node cultures, inflammatory cell infiltrates, epithelial hyperplasia, subcuticular fibrosis, and up-regulated Th2 cytokine and chemokine messages in the skin. Responses to TSLP in various genetically deficient mice demonstrated T cells and eosinophils were required, whereas mast cells and TNF-α were dispensable. TSLP-induced responses were significantly, but not completely reduced in IL-4- and IL-13-deficient mice. These results shed light on the pathways and cell types involved in TSLP-induced inflammation.

Integrity signals

Registry

Crossref · 10.4049/jimmunol.181.6.4311

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mice deficient in IL-13, IL-4R, or IL-13Rβ1, and animals treated with neutralizing antibodies to IL-13 or IL-4R, display reduced fibrosis following many different types of tissue injury.

    “IL-13, IL-4R, and IL-13Rβ1-deficient mice as well as animals treated with neutralizing antibodies to IL-13 or IL-4R display reduced fibrosis following many different types of tissue injury136–140”

    From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [140]

  • Type 2 cytokine signaling has a critical role in the progression of fibrosis.

    “confirming a critical role for type 2 cytokine signaling in the progression of fibrosis”

    From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [140]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jessup, H. K., Brewer, A. W., Omori, M., Rickel, E. A., Budelsky, A. L., Yoon, B.-R. P., Ziegler, S. F., & Comeau, M. R.
Affiliations
  • Amgen (United States) (US)
  • MedImmune , Gathersburg, MD 20878
  • Laboratory for Immune Regulation, Research Center for Allergy and Immunology , Yokohama, Kanagawa,
  • Virginia Mason Medical Center (US)
Venue
The Journal of Immunology
Published
2008-09
Volume
181
Issue
6
Pages
4311-4319
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2117400018
Cited by
110
References
55
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2022: 5 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 6 · 2016: 6 · 2015: 7 · 2014: 8 · 2013: 15 · 2012: 13
FWCI
9.64
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ar056113-05)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01-AR056113)
Topics
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Keywords
thymic stromal lymphopoietin, intradermal administration, type 2 inflammation, T cells, eosinophils, IL-4, IL-13, mast cells, TNF-α, IgE, IgG1, draining lymph nodes, epithelial hyperplasia, skin inflammation, asthma, atopic dermatitis, epithelial-derived cytokines
MeSH terms
Thymic Stromal Lymphopoietin, Animals, Cells, Cultured, Eosinophils, Female, Immunoglobulin E, Injections, Intradermal, Male, Mast Cells, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Nude, Mice, Transgenic, Skin, Thymus Gland, Signal Transduction, Cytokines, Stromal Cells, Immunoglobulin Class Switching, Mice, Knockout, Th2 Cells, Inflammation Mediators, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review